• Most Popular
  • Most Shared

Abraxis gets FDA approval for chemotherapy drug

Wed Oct 17, 2007 8:35am EDT

Stocks

   

Oct 17 (Reuters) - Abraxis BioScience Inc ABBI.O said U.S. health regulators approved its unit, Abraxis Pharmaceutical Products, to market chemotherapy drug Epirubicin hydrochloride injection in four dosage forms, two of which are new to market.

Stocks  |  Regulatory News

The company said the remaining two dosage forms are marketed by Pfizer Inc (PFE.N) as Ellence.

Abraxis expects to launch Epirubicin in single dose vials in the fourth quarter. (Reporting by Ratul Ray Chaudhuri in Bangalore)

Stocks
Regulatory News


More from Reuters

Photo

China's Geely agrees Volvo buy, BAIC eyes expansion

BEIJING/STOCKHOLM (Reuters) - China's automakers Geely and BAIC pushed ahead with plans to harness the technology of Ford's and General Motors' ailing Swedish brands Volvo and Saab in a bid to be global industry players.

» More Top News
Malaysians participate in computer attack and defence hacking competition during The 3rd Annual Hack-In-The-Box Security Conference 2004 in Kuala Lumpur on October 6, 2004. REUTERS/Bazuki Muhammad
Commentary:

Year of the breach

Data security breaches are nasty business and should be avoided at all costs, writes Kevin Prince, a chief technology officer at Perimeter e-Security. Here's a look at the biggest breaches and blunders of 2009.  Commentary 

Technology
A condominium under construction is seen in Miami, Florida October 15, 2007. REUTERS/Carlos Barria

Booming in the bust

For most Americans, the housing market collapsed about four years ago. For three real estate heavyweights, it's just getting started.  Full Article 

Housing Market